These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome of very large superficial bladder tumours: a 10-year experience. Gupta SK; Parr NJ Scand J Urol Nephrol; 2008; 42(3):243-8. PubMed ID: 18432531 [TBL] [Abstract][Full Text] [Related]
3. Is microstaging of early invasive cancer of the urinary bladder possible or useful? Platz CE; Cohen MB; Jones MP; Olson DB; Lynch CF Mod Pathol; 1996 Nov; 9(11):1035-9. PubMed ID: 8933512 [TBL] [Abstract][Full Text] [Related]
4. Analysis of clinical characteristics, management and survival of patients with Ta T1 bladder tumours in Sweden between 1997 and 2001. Gårdmark T; Bladström A; Hellsten S; Malmström PU; Scand J Urol Nephrol; 2006; 40(4):276-82. PubMed ID: 16916767 [TBL] [Abstract][Full Text] [Related]
5. Behavior of urothelial carcinoma with respect to anatomical location. Catto JW; Yates DR; Rehman I; Azzouzi AR; Patterson J; Sibony M; Cussenot O; Hamdy FC J Urol; 2007 May; 177(5):1715-20. PubMed ID: 17437794 [TBL] [Abstract][Full Text] [Related]
6. [Stage T1 tumor of the bladder. From research to prognosis]. Albert P; Leremboure H; Hernandez F; Coulange C; Rampal M Ann Urol (Paris); 1988; 22(4):255-61. PubMed ID: 3056232 [TBL] [Abstract][Full Text] [Related]
7. Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours. Olsson H; Hultman P; Rosell J; Jahnson S Scand J Urol; 2013 Jun; 47(3):188-95. PubMed ID: 22954205 [TBL] [Abstract][Full Text] [Related]
8. Ta T1 low and intermediate transitional cell carcinoma of the bladder: recurrence rates and the timing of check cystoscopies within the first year. Guney S; Guney N; Canogullari Z; Ergenekon E Urol Int; 2008; 80(2):124-8. PubMed ID: 18362479 [TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T; Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [TBL] [Abstract][Full Text] [Related]
10. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. David KA; Milowsky MI; Ritchey J; Carroll PR; Nanus DM J Urol; 2007 Aug; 178(2):451-4. PubMed ID: 17561135 [TBL] [Abstract][Full Text] [Related]
15. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. Zigeuner RE; Hutterer G; Chromecki T; Rehak P; Langner C BJU Int; 2006 Dec; 98(6):1181-6. PubMed ID: 17125475 [TBL] [Abstract][Full Text] [Related]
16. [Bladder tumor in young patients: a series of 26 cases. Comparison with a review of the literature]. Blanchard JM; Graziana JP; Bonnal JL; Biserte J; Mauroy B Prog Urol; 2003 Apr; 13(2):227-33. PubMed ID: 12765056 [TBL] [Abstract][Full Text] [Related]
17. Risk factors for local recurrence in patients with pTa/pT1 urinary bladder cancer. Jancke G; Damm O; Rosell J; Jahnson S Scand J Urol Nephrol; 2008; 42(5):417-21. PubMed ID: 18609266 [TBL] [Abstract][Full Text] [Related]